Literature DB >> 15352892

Review article: joint involvement in inflammatory bowel disease.

M De Vos1.   

Abstract

Peripheral involvement of the joints, including pauciarticular, asymmetrical, transitory and migrating synovitis and enthesiopathy, is observed in 10-20% of affected inflammatory bowel disease patients. Recurrence is common and frequently coincides with a flare-up of intestinal disease. The true prevalence of axial involvement is less well established. Sacroiliitis is a hallmark of spondylitis, but is under-reported due to its insidious onset and sometimes asymptomatic nature. Radiographic evidence of sacroiliitis is present in about 20-25% of patients. Ankylosing spondylitis, as defined by the Rome criteria, is present in 3-10% of inflammatory bowel disease patients, and is thought to have a different genetic predisposition in these patients compared with 'classic' ankylosing spondylitis: whereas the human leucocyte antigen B27 phenotype is present in 90% of patients with 'classic' ankylosing spondylitis, the prevalence decreases to only 30% in patients with ankylosing spondylitis secondary to Crohn's disease. Polymorphisms involving CARD15 appear to be a possible genetic trigger: 78% of patients with Crohn's disease and symptomatic or asymptomatic sacroiliitis carry at least one mutation, compared with only 48% of control Crohn's disease patients. Moreover, in other forms of spondyloarthropathy, a similar association has been reported: 42% of patients with spondyloarthropathy and associated asymptomatic chronic gut inflammation, who are considered likely to develop Crohn's disease and ankylosing spondylitis, are carriers of at least one CARD15 mutation, compared with only 7% of patients with normal histology. In addition to genetic markers, clinical features support the relationship between gut and joint pathophysiology. In cases of spondyloarthropathy, a very rapid, substantial and sustained improvement in symptoms has been reported following treatment with infliximab, suggesting an essential role for tumour necrosis factor-alpha in spondyloarthropathy, similar to that observed in Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15352892     DOI: 10.1111/j.1365-2036.2004.02044.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  13 in total

1.  The association between TNF-alpha promoter polymorphisms and ankylosing spondylitis: a meta-analysis.

Authors:  Bing Li; Pei Wang; Hui Li
Journal:  Clin Rheumatol       Date:  2010-06-11       Impact factor: 2.980

2.  Sacroiliitis is common in Crohn's disease patients with perianal or upper gastrointestinal involvement.

Authors:  Young Hwangbo; Hyo Jong Kim; Ji Seon Park; Kyung Nam Ryu; Nam Hoon Kim; Jaejun Shim; Jae Young Jang; Seok Ho Dong; Byung Ho Kim; Young Woon Chang; Rin Chang
Journal:  Gut Liver       Date:  2010-09-24       Impact factor: 4.519

Review 3.  Extraintestinal manifestations in inflammatory bowel disease.

Authors:  Silvio Danese; Stefano Semeraro; Alfredo Papa; Italia Roberto; Franco Scaldaferri; Giuseppe Fedeli; Giovanni Gasbarrini; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

Review 4.  Extraintestinal manifestations of inflammatory bowel disease: do they influence treatment and outcome?

Authors:  Fernando Tavarela Veloso
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

Review 5.  Diagnosis and treatment of low back pain in the pediatric population.

Authors:  Alysha J Taxter; Nancy A Chauvin; Pamela F Weiss
Journal:  Phys Sportsmed       Date:  2014-02       Impact factor: 2.241

Review 6.  Occult spondyloarthritis in inflammatory bowel disease.

Authors:  Francesca Bandinelli; Mirko Manetti; Lidia Ibba-Manneschi
Journal:  Clin Rheumatol       Date:  2015-09-10       Impact factor: 2.980

7.  Evidence for significant overlap between common risk variants for Crohn's disease and ankylosing spondylitis.

Authors:  Debby Laukens; Michel Georges; Cécile Libioulle; Cynthia Sandor; Myriam Mni; Bert Vander Cruyssen; Harald Peeters; Dirk Elewaut; Martine De Vos
Journal:  PLoS One       Date:  2010-11-02       Impact factor: 3.240

8.  Spondyloarthritis after bariatric surgery: is there a link?

Authors:  Daniel Sá Ribeiro; João Luiz Fernandes; Leandro Rangel; César de Araújo Neto; Fernando D'Almeida; Carlos Geraldo Moura; Mittermayer B Santiago
Journal:  Clin Rheumatol       Date:  2010-01-22       Impact factor: 2.980

Review 9.  Clinical features and epidemiology of spondyloarthritides associated with inflammatory bowel disease.

Authors:  Carlo Salvarani; Walter Fries
Journal:  World J Gastroenterol       Date:  2009-05-28       Impact factor: 5.742

Review 10.  Non-invasive investigation in patients with inflammatory joint disease.

Authors:  Elisabetta Dal Pont; Renata D'Incà; Antonino Caruso; Giacomo-Carlo Sturniolo
Journal:  World J Gastroenterol       Date:  2009-05-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.